Hap Trading, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	BUY	$6.15 - $10.51 $627,761 - $1.07 Million	102,075 Added 246.19%	143,537 $953,000
Q3 2018 Nov 09, 2018	BUY	$10.32 - $13.06 $427,887 - $541,493	41,462 New	41,462 $442,000
Q4 2017 Feb 09, 2018	SELL	$8.77 - $12.28 $1.32 Million - $1.86 Million	-151,078 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$12.17 - $16.3 $1.84 Million - $2.46 Million	151,078	151,078 $1.86 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.